Indian drugmaker says U.S. is hoarding vaccine ingredients

Mar 9, 2021
The CEO of the Serum Institute of India said American raw materials are running out due to Biden administration policy.
The CEO of the Serum Institute of India said at a panel last Thursday that American raw materials are running out. Pictured: A Serum Institute employee works on an assembly line for the AstraZeneca vaccine.
Punit Paranjpe/AFP via Getty Images

Vaccine supply chain bottlenecks eased, drugmakers tell Congress

Feb 23, 2021
Pfizer and others are collaborating to accelerate production. Johnson & Johnson and Novavax may receive FDA approval soon.
In vaccine making, one of the key bottlenecks is filling bottles quickly.
Patrick T. Fallon/AFP via Getty Images